主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
COYA
#3330
Coya Therapeutics, Inc. Common Stock
4.9
6
+1.22%
版块:
基础:
利润货币:
日范围
年范围
日变化
+1.22%
每月变动
+2.06%
6个月变化
-25.30%
年变化
-24.04%
前一天收盘价
4.9
0
Open
4.9
6
Bid
Ask
Low
4.9
6
High
4.9
6
交易量
2
市场
股票
医疗保健
COYA
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
16.71 M
16.72 M
16.72 M
16.73 M
20.92 M
—
Valuation ratios
Enterprise value
76.66 M
57.53 M
72.71 M
66.37 M
91.17 M
287.78 M
Price to earnings ratio
-9.77
-5.85
-6.05
-4.64
-5.14
-21.67
Price to sales ratio
7.75
24.57
26.01
226.96
23.91
301.44
Price to cash flow ratio
-8.6
-8.49
-6.44
-5.53
-7.7
-28.15
Price to book ratio
0.68
2.21
0.71
0.68
0.72
4.31
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.11
-0.07
-0.19
-0.18
-0.07
-0.5
Return on equity %
-0.13
-0.07
-0.22
-0.22
-0.08
-0.59
Return on invested capital %
—
—
-1 557.19
-3 149.88
-998.9
—
Gross margin %
—
100
100
100
100
400
Operating margin %
—
-209.03 K
-2 976.89
-3 920.47
-68.26
-216 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
-149.37 K
-2 833.35
-3 725.17
-59.36
-155.99 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
15.31
11.59
8.84
7.43
8.73
36.58
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0.01
0
0.11
0.12
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.36
-0.16
-0.17
-0.35
-0.07
-0.74
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.04
2.51
2.12
1.78
1.68
8.1
Net current asset value per share
2.33
2.91
2.29
2
1.91
9.12
Tangible book value per share
2.1
2.6
2
1.69
1.63
7.92
Working capital per share
2.18
2.66
2.04
1.73
1.69
8.12
Book value per share
2.1
2.6
2
1.69
1.63
7.92
新闻
H.C. Wainwright 维持Coya Therapeutics股票买入评级,目标价18美元
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target
Coya Therapeutics完成1110万美元私募融资
Coya Therapeutics secures $11.1 million in private placement
Coya Therapeutics推进ALS和FTD临床试验至2026年
Coya Therapeutics advances ALS and FTD clinical trials in 2026
H.C. Wainwright维持Coya Therapeutics股票18美元的买入评级
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock at $18
Tracking David Einhorn’s Greenlight Capital Portfolio – Q3 2025 Update (NYSE:GRBK)
H.C. Wainwright重申Coya Therapeutics股票买入评级
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock
H.C. Wainwright重申Coya Therapeutics股票买入评级,目标价18美元